Top 10 search results for "seem kindness when struggling 6 minute guided medication" in Treatments. To see all results and access other features, sign up for free.

Emgality (Galcanezumab-gnlm)

Overview
Emgality is approved by the Food and Drug Administration (FDA) to prevent migraine in adults. Emgality is also referred to by its drug name, Galcanezumab-gnlm.

Emgality is a biologic drug – a genetically… read more

Tosymra (Sumatriptan nasal spray)

Overview
Tosymra is a prescription drug approved by the Food and Drug Administration (FDA) to treat acute migraine headaches with or without aura in adults. Tosymra is also known by its drug name, Sumatriptan.… read more

Nurtec ODT (Rimegepant)

Overview
Nurtec ODT is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute migraine, with or without aura. Nurtec is also used as a preventative treatment of episodic… read more

GammaCore

Overview
A prescription device, gammaCore is approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of pain associated with migraine headaches in people aged 12 years and older. It is also…

Cefaly

Overview
Cefaly is a U.S. Food and Drug Administration (FDA)-cleared medical device for the treatment and prevention of migraine in individuals aged 18 and older. Two versions of the device are available: Cefaly Enhanced…

Savi Dual

Overview
The Savi Dual Migraine Therapy device is cleared by the U.S. Food and Drug Administration (FDA) for the acute and preventive treatment of migraine in people aged 12 and older. It is available only through a…

Zavzpret (Zavegepant)

Overview
Zavzpret is approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults. It is not indicated for the preventive treatment of migraine. Zavzpret is…

Trudhesa (Dihydroergotamine)

Overview
Trudhesa is approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults. It is not approved for the preventive treatment of migraine or for treating…

Symbravo (Meloxicam and Rizatriptan)

Overview

Symbravo is approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults. It should only be used when a clear diagnosis of migraine has been made…

Atzumi (Dihydroergotamine)

Overview
Atzumi is approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine attacks with or without aura in adults. It is not intended for the prevention of migraine attacks or for…